✨ Free AI Report
Aurobindo Pharma Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Aurobindo Pharma Limited
Company Research

Aurobindo Pharma Limited: Business Overview, Financials & Competitive Analysis

Aurobindo Pharma is a biopharmaceutical company that develops, manufactures, and commercializes generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables across therapeutic areas including CNS...

Analyst-debate audio for Aurobindo Pharma Limited

AskCyborg analysts argue the bull and bear cases for Aurobindo Pharma Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Diversified global pharma with strong generics presence achieving consistent mid-to-high single-digit growth, backed by strategic...

Read the full analyst-debate transcript →
Industry Pharmaceuticals - Generic & Specialty
4 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Aurobindo Pharma Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Aurobindo Pharma Limited Overview

Pro stress-test →

Aurobindo Pharma is a biopharmaceutical company that develops, manufactures, and commercializes generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables across therapeutic areas including CNS, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. The company markets products in over 125 countries with a majority of revenue generated from the United States, making it a critical player in the global generic pharmaceuticals market.

Strategic Profile

Pro stress-test →

Aurobindo derives over 70% of its revenues from international operations, primarily from the U.S. The company plans to expand its product portfolio with high-value products in oncology, hormones, biosimilars, and novel drug delivery solutions, while projecting EBITDA margins of 20-21% and over €1 billion revenue from Europe for FY'26.

Competitive Landscape

Pro stress-test →

Within the Indian pharmaceutical sector, competitors like Sun Pharma and Dr. Reddy's Laboratories have reported strong results driven by U.S. generics businesses and increasing focus on specialty products. Aurobindo's diversified geographical presence and pipeline development in complex generics and biosimilars position it for continued expansion, offering differentiation through strategic geographic and product diversification.

Industry Context

Aurobindo Pharma Limited operates in Pharmaceuticals - Generic & Specialty.

Key facts

Founded: 1986 · Headquarters: Hyderabad, India · Employees: 40,750 · Revenue: $3.76B · Market cap: $7.1B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Aurobindo Pharma Limited.

  • The Pen-G initiative supported by government policy and significant Lannett acquisition present unique growth vectors, with diversified geographical presence positioning Aurobindo for continued expansion
  • Pen-G facility ramp-up is progressing well, with anticipated annual production exceeding 10,000 metric tonnes
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Q3 FY26 earnings showing 8.4% YoY revenue growth to ₹8,646 crores with strong gross margins of 59.7%
  • January 2026Acquisition of Khandelwal Laboratories non-oncology prescription formulations business
  • +2 moreTrack every material event for Aurobindo Pharma Limited as it happens. Explore monitoring →
Get alerted when Aurobindo Pharma Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Generics BusinessStrong U.S. generics and specialty products→Generics & Specialty ProductsU.S.-driven generics with specialty focus→Generic PharmaceuticalsIndian pharma with global generics presence→Generic PharmaceuticalsDiversified Indian pharma company→

Compare Aurobindo Pharma Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Aurobindo Pharma Limited operates in Pharmaceuticals - Generic & Specialty. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals - Generic & Specialty research →
NEW · MCP server

Ask your AI assistant about Aurobindo Pharma Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Aurobindo Pharma Limited and its top competitor on Cyborg Score”
“What did Aurobindo Pharma Limited do this quarter?”
“Is Aurobindo Pharma Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Aurobindo Pharma Limited do?+
Aurobindo Pharma is a biopharmaceutical company that develops, manufactures, and commercializes generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables across therapeutic areas including CNS...
What is Aurobindo Pharma Limited's Cyborg Score?+
Aurobindo Pharma Limited has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Aurobindo Pharma Limited's main competitors?+
Named competitors include Generics Business, Generics & Specialty Products, Generic Pharmaceuticals, Generic Pharmaceuticals. The full competitive landscape is in the AskCyborg report.
How can I get the full Aurobindo Pharma Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Aurobindo Pharma Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Aurobindo Pharma Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals - Generic & Specialty research

Companies in the same sector and named competitors, ranked by Cyborg Score.

6Teva Pharmaceutical Industries Limited